Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

American Journal of Pathology

Volumn 155, Issue 4, 1999, Pages 1129-1136

  Del Pizzo, Joseph J ^a   Borkowski, Andrew ^a   Jacobs, Stephen C ^a   Kyprianou, Natasha ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P27;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR DIFFERENTIATION; UROTHELIUM;

EID: 0032849914     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65216-9     Document Type: Article

References (39)

1. Messing EM, Catalona W: Urothelial tumors of the urinary tract. Campbell's Urology, ed 7, vol 3. Edited by PC Walsh, AB Retik, ED Vaughan, AJ Wein. Philadelphia, WB Saunders, 1998, pp 2327-2410
2. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
3. Cordon-Cardo C: Mutations of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995, 147:545-560
4. 1 restriction point. Crit Rev Oncol 1996, 7:127-142
5. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994, 266:1821-1828
6. Clurman B, Roberts J: Cell cycle and cancer. J Natl Cancer Inst 1995, 87:1499-1501
7. Weinstein IB, Zhou P: Cell cycle control gene defects and human cancer. Encyclopedia of Cancer, vol 1. Edited by JR Bertino. New York, Academic Press, 1996, pp 256-267
8. Jacks T, Weinberg RA: The expanding role of cell cycle regulators. Science 1998, 280:1035-1036
9. Hussain SP, Harris CC: Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998, 58:4023-4037
10. Hall M, Peters G: Genetic alterations of cyclins, cyclin dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996, 68:67-108
11. 1 oncogene in invasive lobular carcinoma of the breast. Cancer Res 1998, 58:2876-2880
12. Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells. Cancer Res 1998, 58:3448-3454
13. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997, 3:222-225
14. Keyomarsi K, Conte D, Toyofuku W, Fox MP: Deregulation of cyclin E in breast cancer. Oncogene 1995, 11:941-950
15. Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M: Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 1998, 153:681-687
16. 1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996, 110:669-674
17. Kip1 in multistage colorectal carcinogenesis. Cancer Res 1998, 58:114-122
18. Kip1 (evels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst 1998, 90:916-920
19. Salem CE, Tomasic NA, Elmajian DA, Esrig D, Nichols PW, Taylor CR: p53 protein and gene alterations in pathological stage C prostate carcinoma. J Urol 1997, 158:510-514
20. Kip1 protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 1997, 3:2269-2274
21. 1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993, 90:9026-9030
22. Singh SP, Lipman J, Goldman H, Ellis FH, Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagnano M, Loda M: Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 1998, 58:1730-1735
23. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T: p27 expression in gastric carcinoma. Nat Med 1997, 3:593-597
24. Esposito V, Baldi A, DeLuca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi B, Pagano M, Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997, 3381-3385
25. 1 restriction point. Crit Rev Oncol 1996, 7:127-142
26. Hunter T, Pines J: Cyclins and cancer II: cyclin D and Cdk inhibitors come of age. Cell 1994, 79:573-582
27. Rao P, Wilson T: G1 events, and regulation of cell proliferation. Science 1989, 246:603-608
28. Kip1. Cancer Res 1996, 56:1389-1399
29. Kip1 expression. Cell Growth Differ 1997, 8:393-405
30. Keyomarsi K, O'Leary N, Molner G, Lees E, Fingert HJ, Pardee A: Cyclin E, a potential prognostic marker for breast cancer Cancer Res 1994, 54:380-385
31. 1-to-S phase transition. Mol Cell Biol 1995, 15:2612-2624
32. Polyak K, Kato J, Solomon J, Sherr CJ, Massague J, Roberts JM, Koff A: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994, 8:9-22
33. Kip1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 1998, 90:1284-1291
34. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74
35. Loda M, Cukor B, Tam SW, Lavin P, Florentino M, Draetta GF, Jessup JM, Pagano M: Increased proteosome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997, 3:231-234
36. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481
37. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 1992, 84:1251-1261
38. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ: Accumulation of p53 and tumor progression in bladder cancer. N Engl J Med 1994, 331: 1259-1255
39. Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, Cote RJ: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 1998, 160:645-659